PERSPECTIVE THERAPEUTICS

Owners

Goods & Services

Active chemical ingredients for use in the manufacture of anti-cancer drugs; radiopharmaceutical chemical compounds for use in the manufacture of radiopharmaceutical preparations and anti-cancer drugs and for pharmaceutical research and development; radiolabeled chemical compounds comprising alpha-emitting radionuclides for use in the manufacture of radiopharmaceutical preparations and anti-cancer drugs and for pharmaceutical research and development; bifunctional chelating agents for conjugating radionuclides to targeting molecules for use in the manufacture of radiopharmaceutical preparations and anti-cancer drugs and for pharmaceutical research and development; chemical precursors for use in the manufacture of radiopharmaceuticals; chelating compounds for radiolabeling of peptides and small molecules; radioactive isotope-labeled chemical intermediates for pharmaceutical research and manufacturing

Medical and scientific research in the field of cancer treatment and diagnosis; scientific research and development services in the field of radiopharmaceuticals and nuclear medicine; scientific contract research services in the field of radiopharmaceutical drug discovery and development; preclinical research and development services relating to radiolabeled compounds for cancer therapy and diagnosis; scientific consultation services in the field of targeted radionuclide therapy; laboratory research services in the field of radiochemistry and radiopharmaceutical development; drug discovery research services in the field of oncology radiopharmaceuticals; scientific research and technological services relating to the development of targeted alpha therapy compounds; research and development services relating to theranostic radiopharmaceutical platforms

Pharmaceutical products for the treatment of cancer; radiopharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations for the diagnosis of cancer; targeted alpha therapy radiopharmaceutical preparations for the treatment of cancer comprising prostate cancer, breast cancer, pancreatic cancer, colorectal cancer, or neuroendocrine tumors; radioligand therapy preparations comprising radiolabeled targeting compounds for oncological use; radiopharmaceutical diagnostic agents for use in nuclear medicine imaging; radiopharmaceutical preparations for the treatment of cancers; radiolabeled peptide conjugates for use in cancer therapy; radiopharmaceutical preparations for theranostic applications in oncology